Literature DB >> 24512544

Immune reconstitution inflammatory syndrome associated with bacterial infections.

Jean-Christophe Lagier1, Didier Raoult.   

Abstract

INTRODUCTION: Immune reconstitution inflammatory syndrome (IRIS) is defined by various clinical manifestations following the initiation of antiretroviral treatment (ART) in HIV patients primarily infected with Mycobacteria. IRIS has clinical similarities with lepromatous reactions in patients with leprosy following antibiotic initiation. AREAS COVERED: Tuberculosis and more rarely lepromatous leprae and Whipple's disease are the main diseases caused by actinobacteria associated with IRIS, regardless of HIV status. The pathogenesis of this syndrome remains complex and partially understood. The treatment for IRIS is non-evidence-based, except for corticosteroids in tuberculosis-IRIS. Thalidomide and other immunomodulatory drugs have been successfully used in case series. EXPERT OPINION: IRIS is mainly observed during infections (viral, fungal or bacterial) which involve inefficient macrophages for the clearance of bacteria, namely Actinobacteria such as Mycobacterium leprae, M. tuberculosis and Tropheryma whipplei. The restoration of macrophage competence after ART or antibiotic initiation results from a complex mechanism, probably involving a sudden and violent immune reaction with a cytokine storm, such as TNF-α and IFN-γ. This overreaction might be controlled using corticosteroids and thalidomide.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24512544     DOI: 10.1517/14740338.2014.887677

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

1.  Bilateral Ocular Myositis Associated with Whipple's Disease.

Authors:  Vivak Parkash; Hardeep Singh Mudhar; Bart E Wagner; Didier Raoult; Ruth Batty; Hubert Lepidi; John Burke; Paul Collini; Thushan de Silva
Journal:  Ocul Oncol Pathol       Date:  2016-09-07

Review 2.  Neurological immune reconstitution inflammatory response: riding the tide of immune recovery.

Authors:  David B Clifford
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

Review 3.  Repurposing approved drugs on the pathway to novel therapies.

Authors:  Catherine H Schein
Journal:  Med Res Rev       Date:  2019-08-20       Impact factor: 12.944

4.  Intestinal barrier dysfunction mediates Whipple's disease immune reconstitution inflammatory syndrome (IRIS).

Authors:  Julian Friebel; Katina Schinnerling; Anika Geelhaar-Karsch; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Immun Inflamm Dis       Date:  2022-05

5.  Macrophage Polarization in Leprosy-HIV Co-infected Patients.

Authors:  Tatiana Pereira da Silva; Tamiris Lameira Bittencourt; Ariane Leite de Oliveira; Rhana Berto da Silva Prata; Vinicius Menezes; Helen Ferreira; José Augusto da Costa Nery; Eliane Barbosa de Oliveira; Gilberto Marcelo Sperandio da Silva; Euzenir Nunes Sarno; Roberta Olmo Pinheiro
Journal:  Front Immunol       Date:  2020-07-29       Impact factor: 7.561

6.  Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis: A case report.

Authors:  Ping Liu; Ning Pei; Xuhui Liu; Wei Huang; Shuihua Lu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.